Viscarello R R
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut.
Obstet Gynecol Clin North Am. 1990 Sep;17(3):545-55.
Infection with HIV results in a chronic, persistent infection that usually progresses slowly from an asymptomatic state to full-blown AIDS. AIDS remains a lethal disease with no effective cure. A great deal of information has been learned in the past decade, yet many questions remain unresolved. Much more research is needed into the conditions surrounding the perinatal transmission of HIV. Many women who give birth to a child with AIDS are themselves asymptomatic for HIV infection during pregnancy and at delivery; thus, routine voluntary prenatal HIV screening programs must be instituted in areas of high seroprevalence. Such screening programs must provide pretest and post-test counseling with consent and confidentiality. Seroprevalence studies conducted during the perinatal period or at birth using newborn blood samples will provide important epidemiologic data for further research investigations as well as continued estimates of the prevalence of HIV infection. Currently, there is no formal reporting system for HIV infection, only for the clinical expression of AIDS. There may be a need to develop a centralized reporting unit for HIV infection. As the epidemic continues and the true prevalence rates are determined, additional resources for public health care, housing, insurance, and foster care for children will be needed. The number of women who are infected is increasing at an alarming rate. Every opportunity to increase public awareness about the AIDS epidemic and modes of transmission must be exploited if we are to impact on the spread of HIV infection. Prospective studies of pregnant HIV-positive women and pediatric follow-up can provide a wealth of data about AIDS and disease progression in both the mother and the infant. Even if some children do not develop AIDS, the possibility of permanent effects of in utero exposure to the virus still exists. At what exact point in gestation does infection occur? Can infection be prevented or delayed with current chemotherapeutic protocols? Even if a cure or vaccine is developed in the near future, the impact of this deadly virus will have repercussions for many years to come.
感染艾滋病毒会导致慢性持续性感染,通常会从无症状状态缓慢发展为全面的艾滋病。艾滋病仍然是一种致命疾病,尚无有效治愈方法。在过去十年中已经了解到大量信息,但许多问题仍未解决。需要对围产期艾滋病毒传播的相关情况进行更多研究。许多生下患艾滋病孩子的女性在孕期和分娩时自身并无艾滋病毒感染症状;因此,必须在血清阳性率高的地区开展常规自愿产前艾滋病毒筛查项目。此类筛查项目必须在获得同意并保密的情况下提供检测前和检测后咨询。在围产期或出生时使用新生儿血样进行的血清阳性率研究将为进一步的研究调查提供重要的流行病学数据,并持续估算艾滋病毒感染率。目前,尚无针对艾滋病毒感染的正式报告系统,仅有针对艾滋病临床表现的报告系统。可能需要设立一个艾滋病毒感染集中报告单位。随着疫情的持续以及确定真实感染率,将需要为公共医疗、住房、保险和儿童寄养提供更多资源。感染艾滋病毒的女性数量正以惊人的速度增长。如果我们要对艾滋病毒感染的传播产生影响,就必须利用一切机会提高公众对艾滋病疫情及其传播方式的认识。对感染艾滋病毒的孕妇进行前瞻性研究以及对儿童进行随访,可以提供有关艾滋病以及母婴疾病进展的大量数据。即使有些儿童不会患上艾滋病,子宫内接触病毒产生永久性影响的可能性仍然存在。感染究竟发生在妊娠的哪个确切阶段?目前的化疗方案能否预防或延缓感染?即使在不久的将来研发出治愈方法或疫苗,这种致命病毒的影响仍将在未来许多年产生反响。